ホーム > 藤巻基紀/ FUJIMAKI, Motoki

藤巻基紀

FUJIMAKI, Motoki

医学医療系 , 講師
Institute of Medicine , Assistant Professor

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。

1. Hypertrophic olivary degeneration in a patient with lung cancer. Kota Igari; Motoki Fujimaki; Shinji Saiki
Practical neurology (2025)
2. Autophagy-dependent versus autophagy-independent ferroptosis Ye Zhu; Motoki Fujimaki; David C. Rubinsztein
Trends in Cell Biology (2025)
3. Antiproliferative activities through accelerating autophagic flux by basidalin and its analogs in human cancer cells. Tomoe Matagawa; Yukiko Sasazawa; Koki Agui; Motoki Fujimaki (+4 著者) Siro Simizu
Bioorganic & medicinal chemistry letters 104: 129713 (2024)
4. Loss of WIPI4 in neurodegeneration causes autophagy-independent ferroptosis. Ye Zhu; Motoki Fujimaki; Louisa Snape; Ana Lopez (+1 著者) David C Rubinsztein
Nature cell biology 26: 542 (2024)
5. Subacute Progressive Hearing Loss and Lower Body Parkinsonism in Primary Sjögren's Syndrome. Mai Shimizu; Motoki Fujimaki; Eriko Igami; Yuta Ishiguro (+2 著者) Nobutaka Hattori
Internal medicine (Tokyo, Japan) 63: 853 (2024)
6. パーキンソン病初期における甲状腺-肝連関による全身性代謝変化宮本健吾; 斉木臣二; 松本拡高; 鈴木絢未 (+10 著者) 服部信孝
パーキンソン病・運動障害疾患コングレスプログラム・抄録集 17回: 91 (2023)
7. パーキンソン病初期における甲状腺-肝連関による全身性代謝変化宮本健吾; 斉木臣二; 松本拡高; 鈴木絢未 (+10 著者) 服部信孝
パーキンソン病・運動障害疾患コングレスプログラム・抄録集 17回: 91 (2023)
8. Systemic Metabolic Alteration Dependent on the Thyroid-Liver Axis in Early PD. Kengo Miyamoto; Shinji Saiki; Hirotaka Matsumoto; Ayami Suzuki (+10 著者) Nobutaka Hattori
Annals of neurology 93: 303 (2023)
9. Reversible Pisa syndrome caused by chronic subdural hematoma in a patient with Parkinson's disease: a case report. Eriko Igami; Motoki Fujimaki; Mai Shimizu; Yuta Ishiguro (+3 著者) Kazuyuki Noda
BMC neurology 22: 432 (2022)
10. The different autophagy degradation pathways and neurodegeneration. Angeleen Fleming; Mathieu Bourdenx; Motoki Fujimaki; Cansu Karabiyik (+11 著者) David C Rubinsztein
Neuron 110: 935 (2022)
11. Non-invasive diagnostic tool for Parkinson's disease by sebum RNA profile with machine learning. Yuya Uehara; Shin-Ichi Ueno; Haruka Amano-Takeshige; Shuji Suzuki (+6 著者) Nobutaka Hattori
Scientific reports 11: 18550 (2021)
12. Parkinson病患者におけるLevodopa代謝変化と各代謝酵素阻害剤の関係中鏡暁子; 斉木臣二; 高ひかり; 加賀直子 (+9 著者) 服部信孝
パーキンソン病・運動障害疾患コングレスプログラム・抄録集 14回: 102 (2021)
13. Huntingtin-lowering strategies for Huntington's disease. Roger A Barker; Motoki Fujimaki; Priya Rogers; David C Rubinsztein
Expert opinion on investigational drugs 29: 1125 (2020)
14. Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. Haruka Takeshige-Amano; Shinji Saiki; Motoki Fujimaki; Shin-Ichi Ueno (+13 著者) Nobutaka Hattori
Movement disorders : official journal of the Movement Disorder Society 35: 1438 (2020)
15. Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 disease. Shin-Ichi Ueno; Taku Hatano; Ayami Okuzumi; Shinji Saiki (+12 著者) Nobutaka Hattori
Annals of clinical and translational neurology 7: 307 (2020)
16. Mendelian neurodegenerative disease genes involved in autophagy. Eleanna Stamatakou; Lidia Wróbel; Sandra Malmgren Hill; Claudia Puri (+8 著者) David Chaim Rubinsztein
Cell discovery 6: 24 (2020)
17. Neuroprotective effects of memantine via enhancement of autophagy. Kazuoki Hirano; Motoki Fujimaki; Yukiko Sasazawa; Akihiro Yamaguchi (+9 著者) Nobutaka Hattori
Biochemical and biophysical research communications 518: 161 (2019)
18. A metabolic profile of polyamines in parkinson disease: A promising biomarker. Shinji Saiki; Yukiko Sasazawa; Motoki Fujimaki; Koji Kamagata (+15 著者) Nobutaka Hattori
Annals of neurology 86: 251 (2019)
19. Iron Supply via NCOA4-Mediated Ferritin Degradation Maintains Mitochondrial Functions. Motoki Fujimaki; Norihiko Furuya; Shinji Saiki; Taku Amo (+1 著者) Nobutaka Hattori
Molecular and cellular biology 39: (2019)
20. Metabolomics-based identification of metabolic alterations in PARK2. Ayami Okuzumi; Taku Hatano; Shin-Ichi Ueno; Takashi Ogawa (+9 著者) Nobutaka Hattori
Annals of clinical and translational neurology 6: 525 (2019)